Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
Substantial NIH funding for rigorous genomics science if you can build a systematic framework to link individual variants to measurable phenotypes—but you cannot run clinical trials.
Report stale or inaccurate summary
What this is
This NIH UM1 grant supports foundational genomics research aimed at understanding the functional consequences of genetic variation at the individual variant level. The program emphasizes systematic characterization and phenotypic assessment, making it suitable for researchers building comprehensive datasets or analytical frameworks around variant effects. Clinical trials are excluded, positioning this for basic/translational genomics work rather than human subject testing.
Who can apply
Eligible applicants not specified in source material; however, UM1 awards typically support established research institutions (universities, research centers, non-profits). Solo founders and very early-stage startups are unlikely primary targets. Contact NIH for definitive eligibility confirmation. No clinical trials allowed.
Topics: genomic variation · genetic variants · genome function · phenotype assessment · systems biology · variant characterization
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.